Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BrightSpring Health ServicesBTSG +1.26%50 Debt-to-Equity is 1.17 as of Jun. 2026, which is 36% below its 10-year median of 1.84. GuruFocus rates BTSG with a GF Score™ of 50/100 and a GF Value™ of $27.22 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 556 Healthcare Providers & Services companies, BrightSpring Health Services ranks worse than 76.98% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for BrightSpring Health Services's Debt-to-Equity or its related term are showing as below:
BTSG'
s Debt-to-Equity Range Over the Past 10 Years
Min: 1.17 Med: 1.84 Max: 6.28
Current: 1.17
During the past 8 years, the highest Debt-to-Equity Ratio of BrightSpring Health Services was 6.28. The lowest was 1.17. And the median was 1.84.
BTSG's Debt-to-Equity is ranked worse than 76.98% of 556
companies
in the Healthcare Providers & Services industry
Industry Median: 0.405
vs BTSG: 1.17
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
BrightSpring Health Services Debt-to-Equity Related Terms
BrightSpring Health Services Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, BrightSpring Health Services's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BrightSpring Health Services Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, BrightSpring Health Services's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where BrightSpring Health Services's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BrightSpring Health Services (BTSG) has a Debt-to-Equity of 1.17 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on BrightSpring Health Services and its competitors. This is 36% below median its historical median of 1.84. Over the past decade, BrightSpring Health Services' Debt-to-Equity has ranged from 1.17 to 6.28. According to the industry distribution chart, BrightSpring Health Services ranks #428 out of 556 companies in the Healthcare Providers & Services industry, placing it in the top 77%.
Is BrightSpring Health Services' Debt-to-Equity too high?
BrightSpring Health Services' current Debt-to-Equity of 1.17 is 36% below median its 10-year median of 1.84. Over the past 10 years, this metric has ranged from a low of 1.17 to a high of 6.28. The Healthcare Providers & Services industry median Debt-to-Equity is 0.41. BrightSpring Health Services' value of 1.17 is 188.9% above this industry median. Based on the distribution chart, BrightSpring Health Services ranks #428 out of 556 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, BrightSpring Health Services has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BrightSpring Health Services' Debt-to-Equity compare to HQY and TEM?
According to the Healthcare Providers & Services industry distribution chart, BrightSpring Health Services ranks #428 out of 556 companies for Debt-to-Equity. This places BrightSpring Health Services in the lower half of its industry. The industry median Debt-to-Equity is 0.41. BrightSpring Health Services' value of 1.17 is 188.9% above this benchmark. Historically, BrightSpring Health Services' own Debt-to-Equity has ranged from 1.17 to 6.28 over the past decade. While the company's 10-year median is 1.84 vs. the industry median of 0.41, BrightSpring Health Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.41, based on 556 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BrightSpring Health Services's current Debt-to-Equity of 1.17 is 188.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on BrightSpring Health Services and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BrightSpring Health Services's current Debt-to-Equity is 1.17, which is 36% below median its own 10-year median of 1.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BrightSpring Health Services stock overvalued right now?
Based on GuruFocus' analysis, BrightSpring Health Services (BTSG) is currently considered Significantly Overvalued. The stock's GF Value™ is $27.22, compared to a current price of $60.47 — trading 122.1% above its estimated fair value. The current Debt-to-Equity is 1.17, which is 36% below median its 10-year median of 1.84 and 188.9% above the Healthcare Providers & Services industry median of 0.41. BrightSpring Health Services' overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For BrightSpring Health Services (BTSG), the current Debt-to-Equity is 1.17 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BrightSpring Health Services (BTSG) Overvalued in 2026?
Based on GuruFocus' analysis, BrightSpring Health Services stock appears to be overvalued.
The current stock price of $60.47 is trading 122.1% above its estimated GF Value™ of $27.22.
GuruFocus considers BrightSpring Health Services to be Significantly Overvalued.
Key valuation signals for BTSG:
Debt-to-Equity: 1.17 (36% below median its 10-year median of 1.84)
GF Value™: $27.22 vs. price of $60.47 (122.1% above fair value)
Industry Position: 188.9% above the Healthcare Providers & Services median (#428 of 556)
No single metric tells the full story. See the BTSG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
50GF Score
Get the complete analysis for BTSG
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BTSG has been successfully added to your 
